CILINITAB M 25 Mg : MedlinePlus Drug Information.

CILINITAB M 25 Mg

Metoprolol Succinate 23.75 mg & Cilnidipine 10 mg

CILINITAB M 25 is a combination medication used to manage hypertension (high blood pressure). This tablet integrates two active ingredients: Metoprolol Succinate (23.75 mg) and Cilnidipine (10 mg). Metoprolol Succinate is a beta-blocker that affects the heart and circulation, while Cilnidipine is a calcium channel blocker that helps relax the blood vessels. Together, they work synergistically to lower blood pressure more effectively than either component alone.

Composition:

Each tablet of CILINITAB M 25 contains Metoprolol Succinate equivalent to 23.75 mg of Metoprolol Tartrate and 10 mg of Cilnidipine. This combination offers the benefits of both a beta-blocker and a calcium channel blocker, providing a comprehensive approach to blood pressure management.

Uses:

CILINITAB M 25 is prescribed for:

• Treatment of hypertension (high blood pressure), which helps prevent strokes, heart attacks, and kidney problems.
• Management of chest pain (angina).
• Improvement of survival after a heart attack.

Dosage:

The dosage of CILINITAB M 25 should be determined by a healthcare provider based on the patient's medical condition and response to treatment. Typically, it is taken once daily, with or without food. It is crucial to take this medication at the same time each day to maintain consistent blood levels.

Side Effects:

While effective in managing blood pressure, CILINITAB M 25 may cause side effects, including:

• Dizziness or lightheadedness
• Fatigue
• Nausea
• Slow heartbeat
• Cold hands and feet
• Headache

Patients should consult their doctor if these effects persist or if more severe symptoms such as shortness of breath or swelling of the extremities occur.

Price:

The price of CILINITAB M 25 varies by pharmacy location and insurance coverage. It is generally available at a moderate cost, making it a feasible option for long-term management of hypertension.

Precautions:

Before using CILINITAB M 25, patients should discuss their complete medical history with their healthcare provider, especially if they have conditions such as asthma, chronic obstructive pulmonary disease (COPD), diabetes, liver disease, or severe allergies. Both Metoprolol and Cilnidipine may interact with other medications, so it is essential to inform the doctor of all other treatments the patient is undergoing.

Conclusion:

CILINITAB M 25 combines Metoprolol Succinate and Cilnidipine to provide an effective treatment for lowering high blood pressure, thereby reducing the risk of cardiovascular events and enhancing heart health. Adherence to the prescribed regimen and regular medical follow-ups are essential to monitor progress and adjust the treatment as necessary. Always consult with a healthcare professional before starting any new medication to ensure it is suitable for your condition. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. gynecology, Pediatrics, Dental care, and Dermatology.The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

 For further information: 

  EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 BUY NOW